HomeCompareVETTF vs PFE

VETTF vs PFE: Dividend Comparison 2026

VETTF yields 7.17% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VETTF wins by $15.78M in total portfolio value
10 years
VETTF
VETTF
● Live price
7.17%
Share price
$2.23
Annual div
$0.16
5Y div CAGR
60.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15.83M
Annual income
$12,807,063.04
Full VETTF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — VETTF vs PFE

📍 VETTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVETTFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VETTF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VETTF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VETTF
Annual income on $10K today (after 15% tax)
$609.87/yr
After 10yr DRIP, annual income (after tax)
$10,886,003.58/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, VETTF beats the other by $10,863,683.68/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VETTF + PFE for your $10,000?

VETTF: 50%PFE: 50%
100% PFE50/50100% VETTF
Portfolio after 10yr
$7.94M
Annual income
$6,416,660.88/yr
Blended yield
80.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

VETTF
No analyst data
Altman Z
1.9
Piotroski
6/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VETTF buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVETTFPFE
Forward yield7.17%6.13%
Annual dividend / share$0.16$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR60.9%13.2%
Portfolio after 10y$15.83M$49.6K
Annual income after 10y$12,807,063.04$26,258.71
Total dividends collected$15.54M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VETTF vs PFE ($10,000, DRIP)

YearVETTF PortfolioVETTF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,854$1,154.44$9,153$693.39+$2.7KVETTF
2$14,742$2,057.90$8,593$849.25+$6.1KVETTF
3$19,622$3,848.37$8,336$1,066.78+$11.3KVETTF
4$28,699$7,702.68$8,437$1,384.80+$20.3KVETTF
5$47,648$16,940.36$9,013$1,875.40+$38.6KVETTF
6$93,277$42,293.84$10,306$2,680.72+$83.0KVETTF
7$224,310$124,503.11$12,820$4,101.38+$211.5KVETTF
8$690,232$450,220.32$17,673$6,826.70+$672.6KVETTF
9$2,821,811$2,083,263.49$27,543$12,591.86+$2.79MVETTF
10$15,826,401$12,807,063.04$49,560$26,258.71+$15.78MVETTF

VETTF vs PFE: Complete Analysis 2026

VETTFStock

Vector Limited, together with its subsidiaries, engages in electricity and gas distribution, natural gas and LPG sale, gas processing, metering, and telecommunication and new energy solutions businesses in New Zealand. The company operates through Regulated Networks, Gas Trading, and Metering segments. It distributes electricity to residential and commercial customers in Auckland, from Wellsford to Papakura through its network consisting of approximately 18,000 kilometers of overhead lines and underground cables; bulk LPG to commercial customers; and bottled LPG to commercial and residential customers, as well as processes, trades, and sells natural gas. The company also provides Vector solar systems; electricity and gas metering, and data services to approximately 2,000,000 homes and businesses; and designs, builds, and supports fiber network solutions that connect approximately 800 buildings in Auckland. In addition, it offers electric vehicle charging station app; bulk LPG storage, distribution, and management services; trustee and technology services; and ventilation, heating, and water systems and related assembly services. The company is headquartered in Auckland, New Zealand. Vector Limited is a subsidiary of Entrust.

Full VETTF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this VETTF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VETTF vs SCHDVETTF vs JEPIVETTF vs OVETTF vs KOVETTF vs MAINVETTF vs JNJVETTF vs MRKVETTF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.